M&A - Mycotopia Therapies, Inc.

Form Type: 10-K

Filing Date: 2025-04-11

Corporate Action: Acquisition

Type: New

Accession Number: 000109690625000487

Filing Summary: AIBotics, Inc. focuses on the advancement of treatments for mental health problems through the study of psychedelics, utilizing AI technology and acquiring assets from Philon Labs, including intellectual property for the development of AI-powered products. The company's strategic direction includes creating pharmaceutical-grade components for psychedelic treatments and building a supply chain for naturally derived psilocybin-derived compounds, reflecting an alignment with evolving regulations around psychedelics. AIBotics has also engaged in multiple acquisitions and partnership agreements, notably a merger termination with PSLY.com, the development of AI robotic products like the Phill Robot and the Milkyway, and a significant acquisition of assets from Philon Labs, which is expected to enhance their offerings in the wellness industry.

Document Link: View Document